- Report
- February 2024
- 110 Pages
Global
From €4594EUR$4,750USD£3,937GBP
- Report
- January 2022
- 200 Pages
Global
From €7253EUR$7,500USD£6,216GBP
- Report
- March 2021
- 183 Pages
Global
From €3481EUR$3,600USD£2,984GBP
- Report
- February 2022
- 39 Pages
Global
From €1934EUR$2,000USD£1,658GBP
- Report
- September 2023
- 27 Pages
Canada
From €825EUR$914USD£732GBP
- Report
- March 2023
- 125 Pages
Global
From €3500EUR$3,877USD£3,105GBP
- Drug Pipelines
- July 2020
- 46 Pages
Global
From €1934EUR$2,000USD£1,658GBP
- Report
- October 2023
- 22 Pages
Pakistan
From €825EUR$914USD£732GBP
- Report
- September 2023
- 23 Pages
Indonesia
From €825EUR$914USD£732GBP
- Report
- September 2021
- 26 Pages
Ukraine
From €825EUR$914USD£732GBP
- Report
- September 2023
- 47 Pages
United States
From €1059EUR$1,095USD£908GBP
The Cold Drug market is a subset of the Cough and Cold Drugs industry, which includes medications used to treat symptoms of the common cold, such as sore throat, nasal congestion, and cough. These drugs are available in a variety of forms, including tablets, capsules, syrups, and liquids. Many of these drugs contain active ingredients such as acetaminophen, ibuprofen, and dextromethorphan, which are used to reduce fever, pain, and cough. In addition, some cold drugs contain antihistamines, decongestants, and expectorants, which are used to reduce nasal congestion and loosen mucus.
The Cold Drug market is highly competitive, with many companies offering a wide range of products. Some of the major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Novartis, Sanofi, Merck, and Bayer. Show Less Read more